Find a Doctor Search
Cancer Types Treated: Hodgkin Lymphoma, Non-Hodgkin Lymphoma
Dr. Hien Liu is Medical Director of the Apheresis Unit and an Associate Member in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr. Liu earned her MD from the University of Michigan Medical School. She completed an Internal Medicine Residency at Michigan State University/Grand Rapids Medical Education and Research Center. Dr. Liu completed a Hematology/Oncology Fellowship at Cleveland Clinic Foundation, where she also served as Chief Fellow. Prior to joining Moffitt, Dr. Liu was an Assistant Professor at Cleveland Clinic Lerner College of Medicine and Associate Member at Case Comprehensive Cancer Center, Cleveland, Ohio. Dr. Liu is an experienced blood and marrow transplant physician, specializing in autologous and allogeneic transplant for lymphoid malignancies, as well as chimeric antigen receptor (CAR) T-cell therapy. Her clinical and research interests include peripheral blood stem cell mobilization strategies, leukapheresis for CAR T, and therapeutic photopheresis. Dr. Liu leads the Moffitt Apheresis Unit, where peripheral blood stem cell collections for hematopoietic stem cell transplant donors and cellular therapy patients are performed. In addition, she is part of the team of lymphoma physicians that see and perform CAR T-cell therapy for lymphoid cancers.
Education & Training
- Medical Oncology
- Cleveland Clinic Foundation - Hematology/Oncology
- Michigan State University/Grand Rapids Medical Education and Research Center - Internal Medicine
- University of Michigan Medical School - MD
If you believe you are eligible for one of these trials or studies, please call
- Winter A, Rybicki L, Shah SN, Jagadeesh D, Gerds AT, Hamilton BK, Liu H, Dean R, Sobecks R, Pohlman B, Smith M, Kalaycio M, Bolwell BJ, Majhail NS, Hill BT. Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. Leuk Lymphoma. 2018 May;59(5):1195-1201. Pubmedid: 28853617.
- Sawalha Y, Hill BT, Rybicki LA, Sun D, Dean RM, Jagadeesh D, Hamilton BK, Gerds AT, Sobecks RM, Andresen S, Liu HK, Majhail NS, Pohlman B, Kalaycio ME, Bolwell BJ, Smith MR. Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience. Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e95-e102. Pubmedid: 29208403.
- Patel SS, Rybicki LA, Corrigan D, Bolwell B, Dean R, Liu H, Gerds AT, Hanna R, Hill B, Jagadeesh D, Kalaycio M, Pohlman B, Sobecks R, Majhail NS, Hamilton BK. Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Tr. 2018 Jan. Pubmedid: 29369800.
- Mustafa Ali M, Abounader DM, Rybicki LA, Yurch MA, Starn J, Ferraro C, Winslow V, Hamilton BK, Gerds AT, Liu H, Dean R, Hill BT, Pohlman B, Andresen S, Hanna R, Kalaycio M, Bolwell BJ, Majhail NS, Sobecks RM. Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400 cGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome. Biol Blood Marrow Tr. 2017 May;23(5):776-781. Pubmedid: 28108271.
- Gokhale A, Quraishy N, Veemara V, Howdyshell H, Murray L, Royer J, Salmi L, Ricci K, Liu H. Clotting during autologous hematopoietic progenitor cells collection. J Clin Apher. 2017 Dec;32(6):560-561. Pubmedid: 28485035.
- Gokhale A, Quraishy N, Royer J, Howdyshell H, Murray L, Salmi L, Veemara V, Ricci K, Liu H. Centrifuge bowl leak during extracorporeal photopheresis. Transfusion. 2017 Aug;57(8):1860-1861. Pubmedid: 28782819.
- Hill BT, Rybicki L, Carlstrom KD, Jagadeesh D, Gerds A, Hamilton B, Liu H, Dean R, Sobecks R, Pohlman B, Andresen S, Kalaycio M, Bolwell BJ, Majhail NS. Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation. Biol Blood Marrow Tr. 2016 Sep;22(9):1588-1595. Pubmedid: 27343718.
- Hong S, Rybicki L, Abounader DM, Bolwell BJ, Dean R, Gerds AT, Hamilton BK, Hill BT, Jagadeesh D, Kalaycio M, Liu HD, Pohlman B, Sobecks R, Majhail NS. Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma. Bone Marrow Transplant. 2016 Sep;51(9):1191-1196. Pubmedid: 27111046.
- Liu HD. The Cost of Mobilization. Biol Blood Marrow Tr. 2016 Oct;22(10):1735-1736. Pubmedid: 27538375.
- Hong S, Valent J, Rybicki L, Abounader D, Bolwell B, Dean R, Gerds AT, Jagadeesh D, Hamilton BK, Hill B, Kalaycio ME, Pohlman B, Reu F, Samaras C, Sobecks R, Majhail NS, Liu HD. Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy. Bone Marrow Transplant. 2016 May;51(5):732-734. Pubmedid: 26726941.
- Hong S, Rybicki L, Abounader D, Bolwell BJ, Dean R, Gerds AT, Hamilton BK, Hill BT, Jagadeesh D, Kalaycio M, Liu HD, Pohlman B, Sobecks R, Majhail NS. Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biol Blood Marrow Tr. 2016 Jun;22(6):1141-1144. Pubmedid: 26995694.